Cargando…

Proton pump inhibitors with calcium acetate on serum phosphorus levels in hemodialysis patients

BACKGROUND: The increase in serum phosphorus level is an independent risk factor for mortality in patients with chronic renal failure or undergoing dialysis due to end-stage renal disease. Proton pump inhibitors (PPI) are the general name given to agents used to suppress stomach acid. In this study,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cekiç, Deniz, Sipahi, Savaş, Emir Arman, Mehmet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Babol University of Medical Sciences 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646360/ https://www.ncbi.nlm.nih.gov/pubmed/38024165 http://dx.doi.org/10.22088/cjim.14.4.737

Ejemplares similares

Influence of proton pump inhibitors and histamine H(2) receptor antagonists on serum phosphorus level control by calcium carbonate in patients undergoing hemodialysis: a retrospective medical chart review
por: Tatsuzawa, Masaomi, et al.
Publicado: (2016)

An Optical Method for Serum Calcium and Phosphorus Level Assessment during Hemodialysis
por: Holmar, Jana, et al.
Publicado: (2015)

Serum calcium and phosphorus levels in patients undergoing maintenance hemodialysis: A multicentre study in Korea
por: Kim, Gheun-Ho, et al.
Publicado: (2014)

Proton Pump Inhibitor Usage and the Risk of Mortality in Hemodialysis Patients
por: de Francisco, Angel L.M., et al.
Publicado: (2017)

Prime determinants of serum phosphorus level in hemodialysis patients
Publicado: (2014)

Do Proton Pump Inhibitors Decrease Calcium Absorption?
por: Hansen, Karen E, et al.
Publicado: (2010)

Increased Proton Pump Inhibitors−Induced Mortality Risk in Hemodialysis Patients
por: Sertorio, Jonas T., et al.
Publicado: (2018)

Proton Pump Inhibitors and Serum Magnesium Levels in Patients With Torsades de Pointes
por: Lazzerini, Pietro E., et al.
Publicado: (2018)

Effects of Proton Pump Inhibitors on Patient Survival in Patients Undergoing Maintenance Hemodialysis
por: Kang, Seok Hui, et al.
Publicado: (2023)

Leptospirosis during the COVID-19 pandemic: a case report
por: Arman, Mehmet Emir, et al.
Publicado: (2023)

Serum phosphorus levels and pill burden are inversely associated with adherence in patients on hemodialysis
por: Wang, Steven, et al.
Publicado: (2014)

The relationship between proton pump inhibitor use and serum magnesium concentration among hemodialysis patients: a cross-sectional study
por: Misra, Paraish S., et al.
Publicado: (2015)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Frequency of maintenance hemodialysis patients meeting K/DOQI criteria for serum calcium, phosphorus, calcium phosphorus product and PTH levels; a single institutional experience from Pakistan: a cross sectional study
por: Janjua, Taimoor Khalid, et al.
Publicado: (2019)

Calcium Acetate or Calcium Carbonate for Hyperphosphatemia of Hemodialysis Patients: A Meta-Analysis
por: Wang, Yong, et al.
Publicado: (2015)

Proton Pump Inhibitor Use and Magnesium Concentrations in Hemodialysis Patients: A Cross-Sectional Study
por: Nakashima, Akio, et al.
Publicado: (2015)

Proton pump inhibitor as an independent factor of progression of abdominal aortic calcification in patients on maintenance hemodialysis
por: Okamoto, Teppei, et al.
Publicado: (2018)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Serum phosphorus and calcium levels, and kidney disease progression in immunoglobulin A nephropathy
por: Yu, Guizhen, et al.
Publicado: (2021)

Phosphorus Consumption Within 1 Hour Prior to Blood Work and Associated Serum Levels of Phosphate, Calcium, and PTH in Adult Patients Receiving Hemodialysis Treatment
por: Mazzetti, Tom, et al.
Publicado: (2019)

Alexithymia, Phosphorus Levels, and Sleep Disorders in Patients on Hemodialysis
por: Pojatić, Đorđe, et al.
Publicado: (2022)

PS212. Effects of Proton Pump Inhibitors (PPI) on the Serum Concentrations of Venlafaxine
por: Paulzen, Michael, et al.
Publicado: (2016)

Endoscopic findings of dyspeptic patients unresponsive to proton pump inhibitors
por: Sahin, Mestan, et al.
Publicado: (2015)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
por: Shin, Jai Moo, et al.
Publicado: (2013)

Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013)

Use and overuse of proton pump inhibitors
por: Staiano, Annamaria, et al.
Publicado: (2015)

Symptomatic hypomagnesemia and proton pump inhibitors
por: Tin, Sim Sai, et al.
Publicado: (2014)

Evaluation of Antimicrobial Efficacy of Calcium Hydroxide along with Proton Pump Inhibitor against Enterococcus Faecalis
por: Divakar, Namitha, et al.
Publicado: (2020)

Bioimpacts of dialyzer variety on phosphorus level in Iranian hemodialysis patients
por: Pezeshgi, Aiyoub, et al.
Publicado: (2016)

Changes With Lanthanum Carbonate, Calcium Acetate, and Phosphorus Restriction in CKD: A Randomized Controlled Trial
por: Kovesdy, Csaba P., et al.
Publicado: (2018)

Proton-Pump Inhibitors and Serum Concentrations of Uremic Toxins in Patients with Chronic Kidney Disease
por: El Chamieh, Carolla, et al.
Publicado: (2023)

Correlation between the Serum Pepsinogen I Level and the Symptom Degree in Proton Pump Inhibitor-Users Administered with a Probiotic
por: Igarashi, Muneki, et al.
Publicado: (2014)

Relationship between the target dose for hemodialysis adequacy and nutritional assessment
por: Kaya, Tezcan, et al.
Publicado: (2016)

Effect of Proton Pump Inhibitors on the Serum Concentrations of the Selective Serotonin Reuptake Inhibitors Citalopram, Escitalopram, and Sertraline
por: Gjestad, Caroline, et al.
Publicado: (2015)

Effects of Dietary Phosphorus Level on the Expression of Calcium and Phosphorus Transporters in Laying Hens
por: Li, Peng, et al.
Publicado: (2018)

Risk of Pyogenic Liver Abscess in Proton Pump Inhibitor Users: New Inventory of Proton Pump Inhibitor Induced Complications?
por: Bang, Ki Bae
Publicado: (2021)

Characteristics and mortality determinants of COVID-19 patients undergoing hemodialysis
por: SİPAHİ, Savaş, et al.
Publicado: (2021)

Serum Phosphorus Level Rises in US Hemodialysis Patients Over the Past Decade: A DOPPS Special Report
por: Guedes, Murilo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cat92puof4auijbfm3ehhproij